Business Wire·Aug 12, 2026, 4:05 PM ET

Kimball Electronics Reports Q4 Results; Company Provides Guidance for Fiscal 2027 Highlighted by Organic Sales Growth and Accretive Impact of the Helvoet Acquisition

Kimball Electronics reported Q4 2026 net sales of $371.6 million, a 5% sequential increase with gains across all end-market verticals.
The company recorded operating income of $29.1 million (7.8% margin) and adjusted operating income of $18.1 million (4.9% margin) for the quarter.
Cash from operations reached $42.4 million, marking the tenth consecutive quarter of positive operating cash generation.
Total debt decreased to $116.6 million, the lowest level in over four years, supported by cash of $88.9 million.
Cash Conversion Days improved to 82, the best result in 17 quarters.
Kimball Electronics repurchased 83,000 shares for $2.1 million during the fourth quarter.
Full fiscal year 2026 net sales totaled $1,431.4 million, with the Medical vertical growing over 10% after normalizing for a consigned inventory sale.
Fiscal 2026 operating income was $66.1 million, while the company generated $72.3 million in operating cash flow.
The company provided fiscal 2027 guidance projecting net sales between $1,535 million and $1,560 million, representing a 7% to 9% increase.
Fiscal 2027 guidance includes organic sales growth of 3% to 5%, with the Medical vertical expected to grow in the high single to low double-digit range.
Helvoet Polymer Technologies is expected to contribute approximately $60 million in sales during fiscal 2027.
Adjusted operating income margin for fiscal 2027 is projected between 4.4% and 4.7% of net sales.
Capital expenditures for fiscal 2027 are expected to range from $50 million to $60 million.
CEO Richard D. Phillips highlighted the strategic use of a strengthened balance sheet for investments in the medical CDMO space, including a new Indianapolis facility.
The Medical vertical is projected to represent more than one-third of total company sales in fiscal 2027.